Ann: Shareholder Update March 2019, page-5

Well we can't complain that we have not been provided dates / time frames in this announcement ... Launching in April / May in ANZ and it looks like they have undertaken a number of 'training and promotional' events to raise awareness between GP's, Pharmacists, Sales Staff etc etc

Things seem to be moving in the right direction for Munipharma as well .... and I did find it interesting to read this bit re: FDA/USA:


› FDA meeting to discuss VivaGel® BV approval in the US

In preparation for the upcoming meeting with the FDA, Starpharma has completed and submitted a comprehensive package of information, including further analyses of existing clinical data for VivaGel® BV. A meeting with the FDA is expected to occur in the second week of April 2019, subject to final confirmation of availability of all parties. The meeting will be attended by senior representatives of Starpharma as well as internationally recognised KOLs in the area of BV, and the Company’s expert FDA regulatory consultants.

Looks like they are giving it a red hot go to get this over the line without a new trial .... assuming the ex FDA employees (experts) have assisted in the preparation of this further filing of information means that we have in fact 'met the brief" this time around ?  

I read this update in a positive light so GLTAH